The EPS projection of PerkinElmer, Inc. (NYSE:PKI) for quarter ended 2016-09-30 is $0.67. Last week, the projection for EPS was $0.67 against target of $0.67, a month earlier. While 2-months ago, this projection was $0.67 versus forecast of $0.67a quarter months earlier, posting a deviation of 0%.
PerkinElmer, Inc. (NYSE:PKI) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 6, and 6, correspondingly.
The per-share earnings downgrade for PerkinElmer, Inc. (NYSE:PKI) in the preceding 30 and 120 were 0 and 1. While in 60 and 90 days were 1, and 1, in that order.
PerkinElmer, Inc. (NYSE:PKI) EPS target was $0.67 for the quarter closed 1. It was based on 10 calls. As on 2016-05-05 the EPS was $0.56. The change was $0.05, posting a deviation of 9.8%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
PerkinElmer, Inc. (NYSE:PKI) sales prediction for the fiscal 2017 stands at $660.973 and the median estimate is at $660.973. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $661.846 while the lowest target is $660.1 showing standard deviation of 1.234%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of 1.113%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...